GL9 Stock Overview
Operates as a nutrition company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Glanbia plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €14.57 |
| 52 Week High | €19.43 |
| 52 Week Low | €14.00 |
| Beta | 0.51 |
| 11 Month Change | -0.34% |
| 3 Month Change | -4.77% |
| 1 Year Change | 0.34% |
| 33 Year Change | 11.22% |
| 5 Year Change | 39.83% |
| Change since IPO | 34.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| GL9 | DE Food | DE Market | |
|---|---|---|---|
| 7D | 3.8% | -0.7% | -0.02% |
| 1Y | 0.3% | -9.2% | 8.2% |
Return vs Industry: GL9 exceeded the German Food industry which returned -9.1% over the past year.
Return vs Market: GL9 underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| GL9 volatility | |
|---|---|
| GL9 Average Weekly Movement | 9.0% |
| Food Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: GL9's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: GL9's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 5,534 | Hugh McGuire | www.glanbia.com |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Glanbia plc Fundamentals Summary
| GL9 fundamental statistics | |
|---|---|
| Market cap | €3.79b |
| Earnings (TTM) | €285.50m |
| Revenue (TTM) | €4.29b |
13.3x
P/E Ratio0.9x
P/S RatioIs GL9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GL9 income statement (TTM) | |
|---|---|
| Revenue | US$4.47b |
| Cost of Revenue | US$3.27b |
| Gross Profit | US$1.20b |
| Other Expenses | US$906.60m |
| Earnings | US$297.30m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.16 |
| Gross Margin | 26.94% |
| Net Profit Margin | 6.65% |
| Debt/Equity Ratio | 44.0% |
How did GL9 perform over the long term?
See historical performance and comparison